Clinical Trial Update: A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases [Phase 2]

View source ↗

Summary

A Phase II study is evaluating SHR-A1811 in combination with radiotherapy for breast cancer with brain metastases (HER2-positive and HER2-low subtypes); the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Brain Metastases

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Breast Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING